155 related articles for article (PubMed ID: 37932553)
1. Etanercept Ameliorates Vascular, Endocrine, and Ovarian Changes in a Rat Model of DHEA-Induced Polycystic Ovary Syndrome.
Utkan Korun ZE; Gocmez SS; Furat Rencber S; Kavram Sarıhan K; Eraldemir FC; Sahin D
Reprod Sci; 2024 Mar; 31(3):714-726. PubMed ID: 37932553
[TBL] [Abstract][Full Text] [Related]
2. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats.
Rababa'h AM; Matani BR; Ababneh MA
Life Sci; 2020 Nov; 261():118353. PubMed ID: 32877649
[TBL] [Abstract][Full Text] [Related]
3. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.
Mahmoud AA; Elfiky AM; Abo-Zeid FS
Steroids; 2022 Jan; 177():108936. PubMed ID: 34752810
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Metabolic activity in Dehydroepiandrosterone-Induced Polycystic Ovary in Wistar rats Treated with Aspirin.
Olaniyan OT; Bamidele O; Uche S; Femi A; Ayobami D; Ayoola O; Builders M; Mali PC
JBRA Assist Reprod; 2020 Jan; 24(1):41-54. PubMed ID: 31608617
[TBL] [Abstract][Full Text] [Related]
5. ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole.
Lang Q; Yidong X; Xueguang Z; Sixian W; Wenming X; Tao Z
PLoS One; 2019; 14(6):e0217495. PubMed ID: 31170164
[TBL] [Abstract][Full Text] [Related]
6. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E
J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542
[TBL] [Abstract][Full Text] [Related]
7. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes.
Wu H; Zhao B; Yao Q; Kang J
J Ovarian Res; 2023 Oct; 16(1):207. PubMed ID: 37880784
[TBL] [Abstract][Full Text] [Related]
9. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ
Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684
[TBL] [Abstract][Full Text] [Related]
10. Agaricus Subrufescens ameliorates ovarian dysfunction and regulates altered biochemical parameters in rats with Letrozole induced polycystic ovarian syndrome.
Bukke SPN; Pathange BBR; Karumanchi SK; Marri J; Boyina R; Rachamsetty K; Manchikalapati B; Odoma S; Hussaini B
J Ovarian Res; 2023 Nov; 16(1):221. PubMed ID: 37993900
[TBL] [Abstract][Full Text] [Related]
11. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y
Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058
[TBL] [Abstract][Full Text] [Related]
13. Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats.
Jang M; Lee MJ; Lee JM; Bae CS; Kim SH; Ryu JH; Cho IH
PLoS One; 2014; 9(2):e87623. PubMed ID: 24520334
[TBL] [Abstract][Full Text] [Related]
14. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
[TBL] [Abstract][Full Text] [Related]
15. Quercetin modulates granulosa cell mRNA androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in Wistar rats via metabolic and hormonal pathways.
Olaniyan OT; Bamidele O; Adetunji CO; Priscilla B; Femi A; Ayobami D; Okotie G; Oluwaseun I; Olugbenga E; Mali PC
J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32160160
[TBL] [Abstract][Full Text] [Related]
16. Apigenin exerts protective effect and restores ovarian function in dehydroepiandrosterone induced polycystic ovary syndrome rats: a biochemical and histological analysis.
Peng F; Hu Y; Peng S; Zeng N; Shi L
Ann Med; 2022 Dec; 54(1):578-587. PubMed ID: 35152800
[TBL] [Abstract][Full Text] [Related]
17. Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.
Yu F; Xue Y; Zhao Y; Zhang L; He X; Liu Z
Gynecol Endocrinol; 2023 Dec; 39(1):2183045. PubMed ID: 36842967
[TBL] [Abstract][Full Text] [Related]
18. Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway
Zhou J; Tan Y; Wang X; Zhu M
Aging (Albany NY); 2021 Feb; 13(5):7084-7095. PubMed ID: 33638949
[TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome.
Li Y; Zheng Q; Sun D; Cui X; Chen S; Bulbul A; Liu S; Yan Q
J Cell Physiol; 2019 May; 234(5):7435-7447. PubMed ID: 30580448
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome.
Abramovich D; Irusta G; Bas D; Cataldi NI; Parborell F; Tesone M
Endocrinology; 2012 Jul; 153(7):3446-56. PubMed ID: 22577112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
